Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript

Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024

Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Hello, and welcome to the Genmab First Quarter 2024 Conference Call. As a reminder, this conference call is being recorded. During this telephone conference, you may be presented with...